In a different subtype of PH, associated with heart failure with preserved ejection fraction (PH-HFpEF), chronic oral nitrite treatment has been shown to potentially prevent disease progression through activation of the SIRT3- AMPK-GLUT4 signaling pathway in skeletal muscle, but not in the lung, LV, RV, or liver [59]. Here, SIRT3 is linked to heart failure.